Nyrada

Nyrada is a pre-clinical stage biotechnology company focused on developing novel small molecule drugs to address cardiovascular, neurodegenerative, and chronic inflammatory diseases. The company aims to become a high-growth bio-pharmaceutical entity specializing in drug discovery and early-stage development, particularly targeting areas with signif... icant unmet clinical needs. Nyrada's current drug development programs include a PCSK9 inhibitor for high LDL-cholesterol, a neuroprotectant for stroke and traumatic brain injury, a treatment for pain from peripheral nerve damage, and a drug for autoimmune diseases like psoriasis. Their innovative approach centers around the benzopyran molecular scaffold to create effective and well-tolerated therapies.Read More